Avanir's drug succeeds in reducing Alzheimer's related agitation

(Reuters) - Avanir Pharmaceuticals Inc said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. The results from the mid-stage study pushed the company's shares up 28 percent before the bell. Avanir said on Monday based on the data it planned to request a meeting with both the U.S. Food and Drug Administration and the European Medicines Agency. Alzheimer's disease is the most common form of dementia and is a progressive neurodegenerative disease eventually leading to death. ...



via Health News Headlines - Yahoo News http://ift.tt/1BFWWuH